Viewing data from:

ERTAPENEM SODIUM

ANDA

ERTAPENEM SODIUM | A218067 | QILU ANTIBIOTICS PHARMACEUTICAL CO LTD

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: INVANZ(TE code: AP)

API Supply Chain8 active DMFs3 inactive

7 active API suppliers hold Drug Master Files for this ingredient.

SOLARA ACTIVE PHARMA SCIENCES LTDERTAPENEM SODIUM

DMF 283912014

ACS DOBFAR SPAERTAPENEM SODIUM

DMF 291022015

APITORIA PHARMA PRIVATE LTDERTAPENEM SODIUM

DMF 303112016

SHANDONG ANHONG PHARMACEUTICAL CO LTDERTAPENEM SODIUM

DMF 307092016

GLAND PHARMA LTDERTAPENEM SODIUM

DMF 324242018

SHANDONG ANHONG PHARMACEUTICAL CO LTDERTAPENEM SODIUM (PROCESS I)

DMF 372322022

JILIN ASYMCHEM PHARMACEUTICALS CO LTDERTAPENEM SODIUM

DMF 374632023

GLAND CHEMICALS PRIVATE LTDERTAPENEM SODIUM

DMF 401912024

PFIZER HEALTHCARE INDIA PVT LTDInactiveERTAPENEM SODIUM

DMF 273482013

ASYMCHEM LABORATORIES FUXIN CO LTDInactiveERTAPENEM SODIUM

DMF 294732015

SUN PHARMACEUTICAL INDUSTRIES LTDInactiveERTAPENEM SODIUM

DMF 301232016

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — EQ 1GM BASE/VIAL

0 patents0 exclusivities▴

INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | Approved: Oct 31, 2024

No patent or exclusivity listings for this strength.